In this presentation, Perfect Day will discuss how it leverages its IP and technology to help companies scale from strain to production, believing that the best way to change the world for the better is to work with others to create broader impact. Specifically, Tim Geistlinger will take the audience through the evolution and launch of 'nth Bio', the company’s enterprise biology business, and the world’s only company that offers end-to-end expertise and services from the earliest stages of molecular development to commercial-scale manufacturing, and the many steps in-between. nth has operated largely behind the scenes for the past two years delivering scale-up production, IP licensing, strain engineering services, and other solutions to a range of food, biomaterials, and pharmaceuticals customers before its debut in late 2022. The potential is exponential.

‍